{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T16:42:39Z","timestamp":1775666559246,"version":"3.50.1"},"reference-count":20,"publisher":"Japanese Society of Internal Medicine","issue":"24","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2022,12,15]]},"DOI":"10.2169\/internalmedicine.0724-22","type":"journal-article","created":{"date-parts":[[2022,10,4]],"date-time":"2022-10-04T22:19:12Z","timestamp":1664921952000},"page":"3659-3666","source":"Crossref","is-referenced-by-count":3,"title":["SARS-CoV-2 Infection upon Leaving the Tokyo 2020 Olympic and Paralympic Games"],"prefix":"10.2169","volume":"61","author":[{"given":"Mitsuyoshi","family":"Urashima","sequence":"first","affiliation":[{"name":"Division of Molecular Epidemiology, the Jikei University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Takao","sequence":"additional","affiliation":[{"name":"Division of Innovation for Medical Information Technology, the Jikei University School of Medicine, Japan"},{"name":"Department of Neurosurgery, the Jikei University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teppei","family":"Sakano","sequence":"additional","affiliation":[{"name":"Division of Innovation for Medical Information Technology, the Jikei University School of Medicine, Japan"},{"name":"Allm, Inc., Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohei","family":"Takeshita","sequence":"additional","affiliation":[{"name":"Division of Innovation for Medical Information Technology, the Jikei University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Infection Control, the Jikei University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Nakazawa","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Infection Control, the Jikei University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Kawai","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, the Jikei University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichi","family":"Murayama","sequence":"additional","affiliation":[{"name":"Division of Innovation for Medical Information Technology, the Jikei University School of Medicine, Japan"},{"name":"Department of Neurosurgery, the Jikei University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. Delta variant: what we know about the science [Internet]. [cited 2022 Jul 14]. Available from: https:\/\/stacks.cdc.gov\/view\/cdc\/108671"},{"key":"2","unstructured":"2. Twohig KA, Nyberg T, Zaidi A, et al.; COVID-19 Genomics UK (COG-UK) Consortium. Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study. Lancet Infect Dis 22: 35-42, 2022."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Lopez Bernal J, Andrews N, Gower C, et al. Effectiveness of COVID-19 vaccines against the B.1.617.2 (delta) variant. N Engl J Med 385: 585-594, 2021.","DOI":"10.1056\/NEJMoa2108891"},{"key":"4","unstructured":"4. Tokyo 2020 Playbooks [Internet]. [cited 2022 Jul 14]. Available from: https:\/\/olympics.com\/ioc\/tokyo-2020-playbooks"},{"key":"5","unstructured":"5. MySOS [Internet]. [cited 2021 May 19]. Available from: https:\/\/www.allm.net\/en\/mysos-en\/"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Massey A, Lindsay S, Seow D, Gordon J, Lowe DJ. Bubble concept for sporting tournaments during the COVID-19 pandemic: Football Club World Cup. BMJ Open Sport Exerc Med 7: e001126, 2021.","DOI":"10.1136\/bmjsem-2021-001126"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Polack FP, Thomas SJ, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine. N Engl J Med 383: 2603-2615, 2020.","DOI":"10.1056\/NEJMoa2034577"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Baden LR, El Sahly HM, Essink B, et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med 384: 403-416, 2021.","DOI":"10.1056\/NEJMoa2035389"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9. Voysey M, Clemens SAC, Madhi SA, et al. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet 397: 99-111, 2021.","DOI":"10.1016\/S0140-6736(20)32661-1"},{"key":"10","unstructured":"10. Logunov DY, Dolzhikova IV, Shcheblyakov DV, et al. Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia. Lancet 397: 671-681, 2021."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Jara A, Undurraga EA, Gonz\u00e1lez C, et al. Effectiveness of an inactivated SARS-CoV-2 vaccine in Chile. N Engl J Med 385: 875-884, 2021.","DOI":"10.1056\/NEJMoa2107715"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Heath PT, Galiza EP, Baxter DN, et al. Safety and efficacy of NVX-CoV2373 COVID-19 vaccine. N Engl J Med 385: 1172-1183, 2021.","DOI":"10.1056\/NEJMoa2107659"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Sadoff J, Gray G, Vandebosch A, et al. Safety and efficacy of single-dose Ad26.COV2.S vaccine against COVID-19. N Engl J Med 384: 2187-2201, 2021.","DOI":"10.1056\/NEJMoa2101544"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Thompson MG, Stenehjem E, Grannis S, et al. Effectiveness of COVID-19 vaccines in ambulatory and inpatient care settings. N Engl J Med 385: 1355-1371, 2021.","DOI":"10.1056\/NEJMoa2110362"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Bergwerk M, Gonen T, Lustig Y, et al. COVID-19 breakthrough infections in vaccinated health care workers. N Engl J Med 385: 1474-1484, 2021.","DOI":"10.1056\/NEJMoa2109072"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Brown CM, Vostok J, Johnson H, et al. Outbreak of SARS-CoV-2 infections, including COVID-19 vaccine breakthrough infections, associated with large public gatherings - Barnstable County, Massachusetts, July 2021. MMWR Morb Mortal Wkly Rep 70: 1059-1062, 2021.","DOI":"10.15585\/mmwr.mm7031e2"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Sparrow AK, Brosseau LM, Harrison RJ, Osterholm MT. Protecting Olympic participants from COVID-19 - the urgent need for a risk-management approach. N Engl J Med 385: e2, 2021.","DOI":"10.1056\/NEJMp2108567"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Letizia AG, Ramos I, Obla A, et al. SARS-CoV-2 transmission among Marine recruits during quarantine. N Engl J Med 383: 2407-2416, 2020.","DOI":"10.1056\/NEJMoa2029717"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Mantovani A, Netea MG. Trained innate immunity, epigenetics, and COVID-19. N Engl J Med 383: 1078-1080, 2020.","DOI":"10.1056\/NEJMcibr2011679"},{"key":"20","unstructured":"20. Games of the XXXII Olympiad. Tokyo 2020 Paralympic Games. Tokyo Metropolitan Government Report [Internet]. [cited 2022 Aug 19]. Available from: https:\/\/www.2020games.metro.tokyo.lg.jp\/TOKYO2020_TMG_Report_en_A3.pdf"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/61\/24\/61_0724-22\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T04:30:56Z","timestamp":1715315456000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/61\/24\/61_0724-22\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,15]]},"references-count":20,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.0724-22","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,15]]},"article-number":"0724-22"}}